Substituted aryl esters of coumarin-3-carboxylic acid and their use as transmembrane serine protease 2 inhibitors and pharmaceutical composition

Patent (Patents)

Pirotte, Bernard; Francotte, Pierre; El Amri, Chahrazade et al.

2023

Permalink
https://hdl.handle.net/2268/313468

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Brevet 2023.pdf

Publisher postprint (593.5 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Pharmacy, pharmacology & toxicology

Inventor :

Pirotte, Bernard ; Université de Liège - ULiège > Département de pharmacie

Francotte, Pierre ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)

El Amri, Chahrazade; Sorbonne Université [FR]

Reboud-Ravaux, Michèle; Sorbonne Université [FR]

Chaaya, Nancy; Sorbonne Université [FR]

Lesenfants, Cindy ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)

Language :

English

Title (54) :

Substituted aryl esters of coumarin-3-carboxylic acid and their use as transmembrane serine protease 2 inhibitors and pharmaceutical composition

Publication date (43-45) :

2023

Filing date (22) :

28 April 2023

Patent/publication number (10-11) :

WO 2023/213728 Al

Patent status (13) :

Priority number (30) :

22290023.5 EP (03.05.2022)

Applicant (71) :

Université de Liège et Université de La Sorbonne

Publication organism (19) :

WIPO

Available on ORBi :

since 20 February 2024

Statistics

Number of views

45 (9 by ULiège)

Number of downloads

3 (3 by ULiège)

More statistics